Have a personal or library account? Click to login
Association Between Inflammatory Markers and Cognitive Impairment in Patients with Asymptomatic Carotid Stenosis Cover

Association Between Inflammatory Markers and Cognitive Impairment in Patients with Asymptomatic Carotid Stenosis

Open Access
|Apr 2024

References

  1. Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, Van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet. 1997;349(9046):151-4. https://doi.org/10.1016/S0140-6736(96)09328-2 PMid:9111537
  2. Johnston SC, O’Meara ES, Manolio TA, Lefkowitz D, O’Leary DH, Goldstein S, et al. Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Internal Med. 2004;140(4):237-47. https://doi.org/10.7326/0003-4819-140-4-200402170-0000 PMid:14970146
  3. Mathiesen EB, Waterloo K, Joakimsen O, Bakke SJ, Jacobsen EA, Bonaa KH. Reduced neuropsychological test performance in asymptomatic carotid stenosis: The tromso study. Neurology. 2004;62(5):695-701. https://doi.org/10.1212/01.wnl.0000113759.80877.1f PMid:15007116
  4. Pettigrew LC, Thomas N, Howard VJ, Veltkamp R, Toole JF. Low mini-mental status predicts mortality in asymptomatic carotid arterial stenosis. Asymptomatic carotid atherosclerosis study investigators. Neurology. 2000;55(1):30-4. https://doi.org/10.1212/wnl.55.1.30 PMid:10891899
  5. Sabeti S, Exner M, Mlekusch W, Amighi J, Quehenberger P, Rumpold H, et al. Prognostic impact of fibrinogen in carotid atherosclerosis: Nonspecific indicator of inflammation or independent predictor of disease progression? Stroke. 2005;36(7):1400-4. https://doi.org/10.1161/01.STR.0000169931.96670.fc PMid:15933258
  6. Elkind M, Cheng J, Albala B, Paik M, Sacco R. Elevated white blood cell count and carotid plaque thickness. The Northern Manhattan stroke study. Stroke. 2001;32(4):842-9. https://doi.org/10.1161/01.str.32.4.842 PMid:11283380
  7. Assayag EB, Bova I, Kesler A, Berliner S, Shapira I, Bornstein NM. Erythrocyte aggregation as an early biomarker in patients with asymptomatic carotid stenosis. Dis Markers. 2008;24(1):33-9. https://doi.org/10.1155/2008/184647 PMid:18057534
  8. Garcia BA, Ruiz C, Chacon P, Sabin JA, Matas M. High-sensitivity C-reactive protein in high-grade carotid stenosis: Risk marker for unstable carotid plaque. J Vasc Surg. 2003;38(5):1018-24. https://doi.org/10.5114/aoms.2013.34533 PMid:14603210
  9. Kablak-Ziembicka A, Przewlocki T, Sokołowski A, Tracz W, Podolec P. Carotid intima-media thickness, hs-CRP and TNF-α are independently associated with cardiovascular event risk in patients with atherosclerotic occlusive disease. Atherosclerosis. 2011;214(1):185-90. https://doi.org/10.1016/j.atherosclerosis.2010.10.017 PMid:21067752
  10. Bond MG, Barnes RW, Riley WA, Wilmoth SK, Chambless LE, Howard G, Owens B, The ARIC Study Group. High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities study (ARIC). J Neuroimag 1991;1:68-73. PMid:10149810
  11. Larner AJ, Mitchell AJ. A meta-analysis of the accuracy of the Addenbrooke’s cognitive examination (ACE) and the Addenbrooke’s cognitive examination-revised (ACE-R) in the detection of dementia. Int Psychogeriatr. 2014;26(4):555-63. https://doi.org/10.1017/S1041610213002329 PMid:24423470
  12. Kwah LK, Diong J. National institutes of health stroke scale (NIHSS). J Physiother. 2014;60(1):61. https://doi.org/10.1016/j.jphys.2013.12.012 PMid:24856948
  13. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340(2):115-26. https://doi.org/10.1056/NEJM199901143400207 PMid: 9887164
  14. Pelisek J, Rudelius M, Zepper P, Poppert H, Reeps C, Schuster T, et al. Multiple biological predictors for vulnerable carotid lesions. Cerebrovasc Dis. 2009;28(6):601-10. https://doi.org/10.1159/000247605 PMid:19844101
  15. Nishida H, Horio T, Suzuki Y, Iwashima Y, Tokudome T, Yoshihara F, et al. Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: Comparison with C-reactive protein. Cytokine. 2011;53(3):342-6. https://doi.org/10.1016/j.cyto.2010.12.005 PMid:21190868
  16. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res. 1999;85(8):e17-24. https://doi.org/10.1161/01.res.85.8.e17 PMid:10521249
  17. Koutouzis M, Rallidis LS, Peros G, Nomikos A, Tzavara V, Barbatis C, et al. Serum interleukin-6 is elevated in symptomatic carotid bifurcation disease. Acta Neurol Scand. 2009;119(2):119-25. https://doi.org/10.1111/j.1600-0404.2008.01068.x PMid:18638042
  18. Zhang L, Pappel K, Sivashanmugam P, Orman ES, Brian L, Exum ST, et al. Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(5):1087-94. https://doi.org/10.1161/ATVBAHA.0000261548.49790.63 PMid:17442899
  19. Huber SA, Sakkinen P, Conze D, Hardin N, Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscl Thromb Vasc Biol. 1999;19(10):2364-7. https://doi.org/10.1161/01.ATV.19.10.2364 PMid:10521365
  20. Elkind MS, Cheng J, Boden-Albala B, Rundek T, Thomas J, Chen H, et al. Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke. 2002;33(1):31-7. https://doi.org/10.1161/hs0102.100531 PMid:11779885
  21. Kyriakidis K, Antoniadis P, Choksy S, Papi RM. Comparative study of protein expression levels of five plaque biomarkers and relation with carotid plaque type classification in patients after carotid endarterectomy. Int J Vasc Med. 2018;2018:4305781. https://doi.org/10.1155/2018/4305781 PMid:30581625
  22. Pearson TA, Mensah GA, Alexander WR, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cerebrovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from centers for disease control and prevention and the American heart association. Circulation. 2003;107(3):499-511. https://doi.org/10.1161/01.cir.0000052939.59093.45 PMid:12551878
  23. Ridker PM, Morrow DA. C-reactive protein, inflammation, and coronary risk. Cardiol Clin. 2003;21(3):315-25. https://doi.org/10.1016/s0733-8651(03)00079-1. PMID: 14621448.
  24. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the predication of cardiovascular disease in women. N Engl J Med. 2000;342(12):836-43. https://doi.org/10.1056/NEJM200003233421202 PMid:10733371
  25. Bruno D, Vignaga SS. Addenbrooke’s cognitive examination III in the diagnosis of dementia: A critical review. Neuropsychiatr Dis Treat. 2019;15:441-7. https://doi.org/10.2147/NDT.S151253 PMid:30858702
  26. Panegyres PK, Berry R, Burchell J. Early dementia screening. Diagnostics (Basel). 2016;6(1):6. https://doi.org/10.3390/diagnostics6010006 PMid:26838803
  27. Fiedorova D, Krulova P, Ressner P, Jaremova V, Slonkova J, Bar M, Skoloudik D, et al. Addenbrooke’s cognitive examination in nondemented patients after stroke. Neuropsychiatry. 2018;8(2):505-12.
  28. Lees RA, Hendry Ba K, Broomfield N, Stott D, Larner AJ, Quinn TJ. Cognitive assessment in stroke: Feasibility and test properties using differing approaches to scoring of incomplete items. Int J Geriatr Psychiatry. 2017;32(10):1072-8. https://doi.org/10.1002/gps.4568 PMid:27526678
  29. Engelter ST, Gostynski M, Papa S, Frei M, Born C, Ajdacic-Gross V, et al. Epidemiology of aphasia attributable to first ischemic stroke: Incidence, severity, fluency, etiology, and thrombolysis. Stroke. 2006;37(6):1379-84. https://doi.org/10.1161/01.STR.0000221815.64093.8c PMid:16690899
  30. Lal BK, Dux MC, Sikdar S, Goldstein C, Khan AA, Yokemick J, et al. Asymptomatic carotid stenosis is associated with cognitive impairment. J Vasc Surg. 2017;66(4):1083-92. https://doi.org/10.1016/j.jvs.2017.04.038 PMid:28712815
  31. Rostamian S, Mahinrad S, Stijnen T, Sabayan B, De Craen AJ. Cognitive impairment and risk of stroke: A systematic review аnd meta-analysis of prospective cohort studies. Stroke. 2014;45(5):1342-8. https://doi.org/10.1161/STROKEAHA.114.004658 PMid:24676778
  32. Arntzen KA, Schirmer H, Johnsen SH, Wilsgaard T, Mathiesen EB. Carotid atherosclerosis predicts lower cognitive test results: A 7-year follow-up study of 4,371 stroke-free subjects. The Tromsø study Cerebrovasc Dis. 2012;33(3):159-65. https://doi.org/10.1159/000334182 PMid:22222422
  33. Romero JR, Beiser A, Seshadri S, Benjamin EJ, Polak JF, Vasan RS, et al. Carotid artery atherosclerosis, MRI indices of brain ischemia, aging and cognitive impairment: The Framingham study. Stroke. 2009;40(5):1590-6. https://doi.org/10.1161/strokeaha.108.535245 PMid:19265054
  34. Martinić-Popović I, Lovrenčić-Huzjan A, Demarin V. Advanced asymptomatic carotid disease and cognitive impairment: An understated link? Stroke Res Treat. 2012;2012:981416. https://doi.org/10.1155/2012/981416 PMid:22577604
Language: English
Page range: 206 - 213
Submitted on: Dec 24, 2023
Accepted on: Feb 19, 2024
Published on: Apr 9, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Elena Joveva, Marija Karakolevska-Ilova, Stefan Perovski, Marijan Jovev, Aleksandar Serafimov, Marija Dimitrovska, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.